Psychosocial implications of learning amyloid PET results in an observational cohort

Alzheimers Dement. 2024 Sep;20(9):6579-6589. doi: 10.1002/alz.14153. Epub 2024 Aug 11.

Abstract

Introduction: Information on the psychosocial impact of Alzheimer's disease (AD) biomarker testing in adults at risk of AD is needed to inform best practices for communicating biomarker results.

Methods: Ninety-nine cognitively unimpaired older adults learned amyloid positron emission tomography (PET) results (mean age = 72.0 ± 4.8, 95% White, 28% elevated amyloid). Linear mixed-effects regression models were used to test the main effects and interaction of PET result × time on psychosocial outcomes up to 6 months after learning results.

Results: A significant interaction of PET result × time was observed for concern about AD (β = 0.28, p = 0.02) and intrusive thoughts and avoidance (β = -0.82, p < 0.001). A main effect of PET result was observed for AD test-related distress (β = 12.09, p < 0.001).

Discussion: Cognitively unimpaired adults learning elevated-amyloid PET results reported mildly intrusive thoughts/avoidance initially following disclosure, but these symptoms decreased over time. Concern about AD dementia and AD biomarker test-related distress remained higher in elevated-amyloid compared to non-elevated-amyloid participants.

Highlights: Longitudinal assessment of psychosocial reactions after amyloid PET disclosure was conducted. Transient highly intrusive thoughts or avoidance after learning elevated amyloid results. Persistent test result-related distress after receiving elevated-amyloid results. There is increased concern about AD dementia after receiving elevated-amyloid results. Happiness and relief are experienced after receiving non-elevated-amyloid results.

Keywords: Alzheimer's; advanced planning; amyloid; biomarker disclosure; cognition; dementia; perceived risk; psychological; psychosocial; risk communication; test‐related distress.

Publication types

  • Observational Study

MeSH terms

  • Aged
  • Alzheimer Disease* / diagnostic imaging
  • Alzheimer Disease* / psychology
  • Amyloid / metabolism
  • Biomarkers*
  • Cohort Studies
  • Female
  • Humans
  • Learning / physiology
  • Male
  • Positron-Emission Tomography*

Substances

  • Biomarkers
  • Amyloid